![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
An Open-Label, Multicenter Study of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin
in US Veterans With Genotype 1 Chronic Hepatitis C Infection: Efficacy and Safety Results of TOPAZ-VA.... .49% had ongoing psych disorders
|
|
|
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Michael Fuchs1, Timothy Morgan2, Mariem Charafeddine3, Norbert Bräu4, Warren Schmidt5, Michael Kozal6, Susanna Naggie7, Ramsey Cheung8, Tami Pilot-Mati as3, Yao Yu3, Kristi ne Richards3,
Victoria Mullally3, Daniel Cohen3, Alexander Monto9, Doris Toro10
1Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, United States; 2VA Long Beach Healthcare System, Long Beach, California, United States; 3AbbVie Inc., North Chicago, Illinois, United States; 4James J. Peters VA Medical Center, Bronx, New York, United States; 5Iowa City VA Healthcare System, Iowa City, Iowa, United States; 6VA Connecticut Healthcare System and Yale University School of Medicine, New Haven, Connecticut, United States; 7Durham VA Medical Center, Durham, North Carolina, United States;
8VA Palo Alto Healthcare System, Palo Alto, California, United States; 9San Francisco VA Medical Center, San Francisco, California, United States; 10VA Caribbean Healthcare System, San Juan, Puerto Rico
![HCV1](../images/111716/111716-6/HCV1.gif)
![HCV2](../images/111716/111716-6/HCV2.gif)
![HCV3](../images/111716/111716-6/HCV3.gif)
![HCV4](../images/111716/111716-6/HCV4.gif)
![HCV5](../images/111716/111716-6/HCV5.gif)
![HCV6](../images/111716/111716-6/HCV6.gif)
![HCV7](../images/111716/111716-6/HCV7.gif)
![HCV8](../images/111716/111716-6/HCV8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|